pharma · Ovarian Cancer · Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer · ANIX
Anixa Biosciences
Anixa Biosciences Inc
Anixa Biosciences clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
San Jose, USA HQ
1982 Founded
12 Employees
Public company Type
ANIX · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Jose, USA
- Founded
- 1982
- Employees
- 12
- Programs
- 2
- Drugs
- 4
- Patents
- 1
Anixa Biosciences projects
0 ClinicalTrials.gov programs sponsored by Anixa Biosciences.
Anixa Biosciences has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Anixa Biosciences have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.